LAMPERTICO, PIETRO
LAMPERTICO, PIETRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Impact of Hepatocellular Carcinoma on the risk of liver decompensation: a comparative analysis of patients with and without HCC: Role of HCC in liver decompensation
2026 A. Martini, M. Iavarone, R. D'Ambrosio, A. Barone, P. Guerra, E. Degasperi, G. Tosetti, E. Alimenti, S. Cagnin, A. Bonato, E. Libralesso, S. Incicco, N. Zeni, R. Gagliardi, V. Calvino, M. Tonon, C. Gambino, P. Pontisso, S. Piano, P. Lampertico, P. Angeli
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono-Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study
2026 R. Viganò, A. Loglio, C. Dibenedetto, P. Carrai, S. Martini, I. Lenci, B. Magro, S. Conti, P. Cortesi, C. Mazzarelli, C. Becchetti, G. Perricone, M. Cucco, M. Carbone, D. Cocchis, E. Farina, L. Pasulo, M. Viganò, M. Sagasta, E. Degasperi, D. Ghinolfi, P. Lampertico, S. Fagiuoli, L. Belli
Real-world evidence supports earlier treatment in HBeAg-positive but not HBeAg-negative chronic hepatitis B virus infection
2026 M. Cornberg, P. Lampertico
The Predictive Role of [18F]FDG PET/CT in Early HCC Recurrence After Liver Transplantation
2026 E. Alimenti, L. Canova, M. Iavarone, G. Aldinio, D. Dondossola, L. Florimonte, E. Franchi, G. Marini, C. Dibenedetto, L. Caccamo, F. Cerini, M. Castellani, C. Quintini, P. Lampertico
Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world data
2026 C. Porta, L. Pradelli, G. Cirotto, M.T. Majorini, O.U. Garay, V. Calvaruso, T. Fasano, L. Napoli, F.G. Foschi, P. Lampertico
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study
2026 A. Palom, E. Degasperi, B. Coco, A. Loglio, A. Ciancio, G. Niro, M. Riveiro-Barciela, A. Carvalho-Gomes, J. García-Samaniego, S. Lens, A. Rando-Segura, D. Sambarino, R. Cotugno, L. Kondili, M. Brunetto, M. Viganò, P. Lampertico, M. Buti
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B
2026 M. Rossi, A. Vecchi, C. Tiezzi, F. Guerrieri, M. Plissonnier, E. Degasperi, D. Sambarino, D. Laccabue, A. Alfieri, E. Gabor, A. Penna, V. Reverberi, A. Montali, A. Pelagatti, S. Doselli, B. Farina, G. Pedrazzi, P. Fisicaro, G. Missale, P. Lampertico, C. Ferrari, M. Levrero, C. Boni
Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF)
2026 S. Gitto, F. Gabrielli, G. Addolorato, C. Tarli, G. Zaccherini, R. Calia, G. Germani, P. Burra, A. Zanetto, F. Ferri, R. D'Ambrosio, P. Toniutto, N. Pugliese, F. Cosci, G. Marrone, C. Celsa, L. Craxì, M. Masarone, D. Saltini, L. Turco, L. Golfieri, S. Pasquato, V. La Mura, P. Lampertico, E.G. Giannini, F. Marra, M.C. Morelli, F. Morisco, I. Gardini, M. Conforti, M. Bartoli, P. Andreone, I. Grattagliano, A.D. Colombo, V. Calvaruso, P. Caraceni
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study
2026 Z.M. Younossi, L. De Avila, S. Petta, H. Hagström, S.U. Kim, A. Nakajima, J. Crespo, L. Castera, N. Alkhouri, M. Zheng, S. Treeprasertsuk, P. Ananchuensook, N. Shalimar, E. Tsochatzis, S.K. Trivikrama, L.K. Balakumaran, J. Fan, S.K. Roberts, K. Alswat, V. Wai-Sun Wong, Y. Yilmaz, W. Dunn, S. Francque, A. Cordie, M. Yu, M. Ekstedt, G. Boon-Bee Goh, C.P. Oliveira, M.G. Pessoa, W.K. Chan, M.I. Castellanos Fernandez, A. Duseja, J.P. Arab, G. Papatheodoridis, G. Sebastiani, C. Villela-Nogueira, R. D'Ambrosio, P. Lampertico, K.M. Alnaamani, A.G. Holleboom, A. Valsan, A. Venu, M. El-Kassas, G. Pennisi, Y. Shang, W. Liu, H.W. Lee, T. Kobayashi, S. Kakizaki, C. Caussy, B. Pearlman, P. Iruzubieta, R. Nadeem, F. Cinque, A. Neonaki, M. Zoncapé, R. Yang, S.J. Song, N. Dunn, Z. Gadi, M. Yeh, K. Kim-Jun Teh, S. Mahadeva, L.G. Fabian, A. Almohsen, N. Leite, N. Pugliese, J. Vessby, C. Xie, N.S. Choudhary, E. Friend, M. Poca, T. Kawaguchi, F.P. Russo, A. Gadano, L.A. Diaz, A.K. Singal, B. Segrestin, N. Gunn, D. Mauricio, M. Arrese, A. Fracanzani, R. Lombardi, A. Aghemo, B. Lam, A. Racila, S.A. Alqahtani, M. Stepanova
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study
2026 G. Caviglia, A. Ferro, R. D'Ambrosio, R. Perbellini, P. Lampertico, G. Periti, L. Valenti, C. Ciccioli, G. Pennisi, S. Petta, L. Brodosi, M. Petroni, F. Marchignoli, L. Pironi, A. Sagripanti, M. Argenziano, G. Svegliati-Baroni, C. Rosso, F. Barutta, A. Armandi, G. Gruden, E. Bugianesi
Classification and sequencing of hepatitis D virus from a large cohort of chronically infected individuals paired with co-infecting hepatitis B virus sequencing: a genomic characterisation study
2026 S. Manhas, S. Chang, R. Martin, A. Lopez, T. Aeschbacher, S. Xu, R. Mateo, Y. Liu, S. Narguet, D. Abdurakhmanov, P. Lampertico, D. Manuilov, J. Flaherty, H. Mo, E. Maiorova
144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and posttreatment results from a Phase 3 randomized trial
2026 H. Wedemeyer, S. Aleman, A. Blank, P. Andreone, P. Bogomolov, V. Chulanov, N. Mamonova, N. Geyvandova, V. Morozov, O. Sagalova, T. Stepanova, A. Berger, S. Ciesek, A. Lichtman, D. Manuilov, R. Mercier, S. Arterburn, F. Christian-Cox, S. Tseng, A. Osinusi, J. Schulze Zur Wiesch, M. Cornberg, S. Zeuzem, M.R. Brunetto, P. Lampertico
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives
2026 P. Invernizzi, A. Aghemo, V. Calvaruso, A. Lleo, M. Marzioni, F. Piscaglia, C. Rigamonti, U. Vespasiani Gentilucci, S. Brillanti, M. Carbone, N. Cazzagon, P. Lampertico
An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia
2026 N. Bitto, G. Tosetti, A. Tripodi, A. Lecchi, S. La Marca, L. Padovan, E. Scalambrino, M. Clerici, C. Caputo, M. Lucà, M. Primignani, A.L. Fracanzani, P. Lampertico, F. Peyvandi, V. La Mura
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
2026 T. Asselah, M. Chattergoon, A. Jucov, A. Streinu-Cercel, P. Lampertico, H. Wedemeyer, P. Kennedy, E. Gane, B. Bullard, S. Chow, D. Santos, G. Camus, Y. Lu, C. Pilowa, C. Hwang, T. Correll, K. Agarwal
Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score
2026 L. Canova, E. Alimenti, L. Argiento, G. Cabibbo, F. Tovoli, E. Di Giacomo, P. Galle, C. Celsa, M. Pinter, T. Marron, C. Vivaldi, A. Dalbeni, F. Marra, A. Palloni, S. Lonardi, F. Ponziani, P. Federico, A. Saeed, A. Pillai, T. Pressiani, S. Camera, G. Svegliati-Baroni, G. Manfredi, L. Lani, J. Von Felden, S. Ulahannan, L. Ielasi, S. De Lorenzo, C. Mazzarelli, R. Sacco, N. Rohlen, M. Silletta, P. Toniutto, S. Ascari, C. Fulgenzi, B. Scheiner, F. Crowley, F. Cerini, P. Lampertico, D. Pinato, M. Iavarone
Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort
2025 B. Coco, M. Quaranta, M. Tosti, L. Ferrigno, G. Brancaccio, A. Ciancio, C. Coppola, V. Messina, I. Gentile, E. Claar, F. Morisco, T. Santantonio, M. Viganò, I. Cacciola, M. Pompili, F. Russo, A. Izzi, G. Niro, N. Coppola, A. Soria, A. Federico, G. Morsica, M. Puoti, E. Villa, P. Lampertico, G. Gaeta, L. Kondili, M. Brunetto
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database
2025 A. Loglio, I. Gardini, M. Conforti, M. Bartoli, F. Silvia, C. Coppola, L. Chessa, G. Svegliati-Baroni, L. Schiadà, I. Gentile, B. Pinchera, M. Brunetto, P. Colombatto, A. Aghemo, S. De Nicola, P. Toniutto, E. Giannini, A. Colecchia, D. Romagnoli, L. Sarmati, F. Ponziani, F. Morisco, C. Cammà, G. Cabibbo, P. Lampertico, E. Degasperi, P. Invernizzi, A. Ciaccio, F. Russo, A. Ippolito, G. Niro, N. Terreni, G. Nardone, A. Rocco, M. D'Antò, D. Sacerdoti, D. Ieluzzi, A. Ciancio, A. Pellicelli, A. Federico, L. Simone, V. Messina, E. Claar, V. Rosato, G. D'Offizi, P. Caraceni, P. Muratori, C. Giaccherini, S. Fagiuoli, M. Viganò
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D
2025 S. D'Anna, R. Salpini, E. Degasperi, L. Piermatteo, F. Facchetti, D. Sambarino, G. Torre, M. Borghi, M. Anolli, S. Monico, V. Svicher, P. Lampertico
Exploring the patient experience of chronic hepatitis D (CHD) and assessment of content validity of the Hepatitis Quality of Life Questionnaire and (HQLQv2) and the Fatigue Severity Scale (FSS)
2025 P. Lampertico, A. Chohan, H. Elwick, N. Williamson, R. Jones, A. Yehoshua, C. Burk, M. Rock, R. Gish, N. Reau, H. Wedemeyer, M. Buti